Lymphoid organs guarantee productive immune cell interactions through the establishment of distinct microenvironmental niches that are built by fibroblastic reticular cells (FRC). These specialized immune-interacting fibroblasts coordinate the migration and positioning of lymphoid and myeloid cells in lymphoid organs and provide essential survival and differentiation factors during homeostasis and immune activation. In this review, we will outline the current knowledge on FRC functions in secondary lymphoid organs such as lymph nodes, spleen and Peyer's patches and will discuss how FRCs contribute to the regulation of immune processes in fat-associated lymphoid clusters.
| FIB ROB L A S TIC RE TI CUL AR CELL S UNDERPIN THE S TRUC TURE OF LYMPHOID ORG ANS
The activation of adaptive immune responses depends on the interaction of professional antigen-presenting cells (APC) with T and B cells in specialized compartments of lymphoid organs. Secondary lymphoid organs (SLO) are strategically positioned at routes of pathogen invasion and thereby increase the likelihood of lymphocytes to encounter their cognate antigens at a particular location and during a certain time window. Lymph nodes are found at convergence points of afferent lymph vessels and surveil extracellular fluids from separate areas of peripheral tissue. Other classical SLO such as Peyer′s patches are located right below the area of the intestinal surface they surveil, while the splenic white pulp provides specialized niches for the development of immune responses against blood-borne pathogens. 1 Nonclassical SLO such as fat-associated lymphoid clusters (FALC) serve as surveillance hubs of the body cavities by sampling the fluids that are secreted by mesothelial cells. 2 Transient lymphoid aggregates that display T-and B-cell zone segregation and that appear in inflamed tissues are referred to as tertiary lymphoid structures (TLS, also known as tertiary lymphoid organs). 3 Fluid flow in lymphoid organs is sustained by endothelial stromal cells with blood endothelial cells facilitating the delivery of oxygen and nutrients via blood vessels and lymphatic endothelial cells granting drainage of extracellular liquids via lymphatic vessels.
The structural integrity of all lymphoid organs is determined by fibroblastic stromal cells that build, for example, the capsule of lymph nodes or the spleen. In addition, specialized immune-interacting fibroblasts, generally termed fibroblastic reticular cells (FRC), form the scaffold structures that underpin the distinct microenvironments required for efficient immune cell interactions (Figure 1 ). FRC crucially contribute to the functioning of the immune system through the secretion of homeostatic chemokines to coordinate the interaction between APC and lymphocytes and provide growth and survival factors that nurture both innate and adaptive lymphocytes. 4, 5 Moreover, FRC are equipped with a large range of pattern recognition receptors [6] [7] [8] that play a crucial role in the control innate immune reactions.
The detection of pathogen-associated molecular signatures by germline-encoded receptors is a key determinant for the immune system to distinguish harmful molecules of foreign origin from inoccuous self-molecules. 9, 10 Sensing of microbial products by pattern recognition receptors expressed by APC such as dendritic cells and macrophages has been considered as a key step for the activation of the adaptive immune system. 9, 11 However, recent studies have revealed that FRC in classical and nonclassical SLO actively shape adaptive immune responses through the integration of innate immunological signals. 8, 12 In this review, we will highlight the ability of FRC to generate tissuespecific microenvironmental niches that orchestrate complex immunological processes and discuss recent work that has revealed the role of FRC as an important nexus of innate and adaptive immune responses.
| D IVER S IT Y OF FIB ROB L A S TI C RE TICUL AR CELL S IN LYMPHOID ORG AN S
The most commonly used distinction of endothelial and fibroblastic stromal cells of SLO relies on the expression of the endothelial marker CD31 (platelet endothelial cell adhesion molecule-1, PECAM-1) and the fibroblast marker podoplanin (PDPN). 13 While PDPN expression captures the majority of FRC in lymph nodes, the expression of this marker in the spleen is restricted mainly to FRC in the T-cell zone. 14 Moreover, PDPN is a surface molecule that is expressed by fibroblasts in nonlymphoid tissues and in tumors 15 rendering this marker unsuitable to specifically track lymphoid tissue FRC. In contrast, the promoter activity of the FRC signature genes Ccl19 and Cxcl13 is well-suited to capture the complexity of the immune-interacting fibroblasts in SLO. 16, 17 Indeed, the Ccl19-Cre model facilitates targeting of FRC in all relevant microenvironments in lymph nodes, 16, 18, 19 in Peyer's patches 12 and in the white pulp of the spleen. 20 Likewise, the Cxcl13-Cre/tdTomato transgene targets the majority of FRC in all SLO. 17 The combination of such advanced transgenic mouse models with single-cell RNA-seq-based analyses of lymph node 7, 21 and splenic white pulp 22 FRC will enable a series of novel studies to further explore the functional complexity of FRC in lymphoid organs.
| The many shapes of FRC in classical secondary lymphoid organs
While the differentiation trajectories of splenic white pulp FRC from perivascular progenitors have been delineated recently using Ccl19 promoter-based cell fate mapping 22 and lineage tracing, 20 the origin of lymph node FRC has not yet been fully elucidated. Nevertheless, the aggregation of Ccl19-Cre + and Cxcl13-Cre + cells in the vicinity of blood vessels of the lymph node anlage 16, 17 strongly suggests that lymph node FRC originate from myofibroblastic progenitors in the perivascular space. It appears that these precursor cells are able to F I G U R E 1 Lymphoid organs are underpinned by distinct fibroblastic reticular cell (FRC) subsets. (A) The structural segregation of classical secondary lymphoid organs (SLO) such as lymph nodes is granted by FRC that form dedicated microenvironmental niches. Marginal reticular cells are underlying the subcapsular sinus floor and form a bridge to the B-cell follicle. The area densely populated by T cells harbors T-cell zone reticular cells (TCR), while perivascular reticular cells from concentric layers around high endothelial venules and other blood vessels. Within the B-cell follicle, follicular dendritic cells (FDC) and CXCL12-producing reticular cells (CRC) regulate B-cell trafficking and the germinal center reaction. The medullary region is rich in lymphatic vessels that are surrounded by medullary reticular cells (medRC). (B) Nonclassical SLO such as fat-associated lymphoid clusters (FALC) lack dedicated subcompartments and are underpinned by CCL19-and/ or CXCL13-expressing FRC. (C) Tertiary lymphoid structures (TLS) form in the vicinity of blood vessels under inflammatory conditions, for example in the lungs as inducible bronchus-associated lymphoid tissue (iBALT). Structural segregation of TLS with T-cell and B-cell areas can occur during long-lasting inflammation with mature TLS harboring TCR-like and FDC-like reticular cells generate the various FRC subsets that underpin the major compartments of the lymph node ( Figure 1A ).
The lymph fluid from peripheral tissues that arrives to the lymph node via the afferent lymph vessels is drained through the subcapsular sinus which is lined by lymphatic endothelial cells and, beneath the subcapsular sinus floor, by several layers of marginal reticular cells (MRC). 23 These cells can be distinguished from other FRC subsets in lymph nodes by the expression of mucosal vascular addressin cell adhesion molecule 1 (MAdCAM-1), receptor activator of nuclear factor kappa-Β ligand (RANKL, TNFSF11), and CXCL13. 23 In the spleen, MRC support immune responsiveness by supporting the capture and delivery of antigens from the marginal zone to Bcell follicles. 24 The expression of RANKL by Ccl19-Cre + lymph node MRC has been shown to be critical for the integrity of lymphatic endothelial cells in the subcapsular sinus 25 26 while RANK has been shown to maintain myeloid cell populations in the marginal zone to secure initiation of antiviral immune responses. 27 As an extension from the MRC layer unfolds the conduit system through the lymph node parenchyma as a fibrillary network formed by FRC. 28 Conduits both in lymph nodes and in the splenic white pulp are ensheathed by FRC and consist of a collagen-rich core that is surrounded by a microfibrillar zone and a basement membrane. 29, 30 The conduit system conveys lowmolecular-weight substances such as chemokines and antigens from the lymph node subcapsular sinus through the T-cell area toward high endothelial venules. 30 A recent report revealed that IgM transiently gains access to the luminal side of the lymph node conduit system to facilitate rapid export of early-response IgM antibodies out of the lymph node parenchyma. 31 In sum, MRC of lymph nodes and the splenic white pulp shape the border region of lymphoid tissues through the dedicated interaction with immune cells and other stromal cells and by maintaining communication channels for rapid distribution of immunologically relevant information. It will be important to fully exploit existing and novel reticular cell targeting approaches (such as the CollagenVI-Cre model 32 ) to characterize the function of MRC in Peyer's patches.
T-cell zone reticular cells (TRC), ie, the FRC that co-localize predominantly with T cells and dendritic cells, express PDPN and the signature chemokines CCL19 and CCL21. [12] [13] [14] 22 It is important to reiterate that PDPN expression in lymph nodes can be found in almost all FRC subsets and that high PDPN expression is associated with maturation into fully immunocompetent FRC, 16 while PDPN expression both in Peyer's patches and in the splenic white pulp is mainly found in TRC. 12, 22 Both T cells and dendritic cells are in close contact with TRC and move along their projections within the T-cell area. 33 The mobility of dendritic cells is boosted by the ligation of the Ctype lectin-like receptor 2 (CLEC-2) with PDPN on TRC. 34 Moreover, lymph node TRC are thought to function as the major source of the cytokine IL-7 to promote T-cell homeostasis. 13 However, since IL-7 can also be produced by lymphatic endothelial cells within lymph nodes 35 and in the afferent lymphatics, 36 the specific function of TRC-derived IL-7 for T-cell sustenance and activation remains to be demonstrated.
B-cell follicles harbor distinct FRC subsets that produce CXCL13, the B cell-attracting chemokine that binds to CXCR5. 37 As mentioned above, CXCL13-expressing MRC extend into the B cell follicle, while the most prominent reticular cell subset that underpins the B-cell area has been named follicular dendritic cell (FDC). 38 Due to their dendritic morphology, FDC have been assumed to be related to conventional dendritic cells, ie, to originate from bone marrow progenitors. Only recently, the progenitor cell of FDC has been revealed as perivascular myofibroblast that is characterized by the expression of plateletderived growth factor receptor β (Pdgfrb, CD140b). 39 FDC in the B cell follicle can be identified by the expression the complement receptors CD21 and CD35 and can be found both in primary and secondary follicles. 40 The main functions of FDC are the retention and presentation of particulate antigen on their surface to B cells using a broad range of FCγ-receptors (ie, CD16, CD32) 41 and the promotion of affinity maturation and somatic hypermutation of B cells in the germinal center reaction. 42 FDC and probably other FRC subsets 43 in the B-cell follicle control the survival of B cells via B cell activation factor (BAFF) or transmembrane activator and CAML interactor (TACI). 44 It has been suggested that the dark zone of the germinal center harbors a subset of CXCL12-expressing reticular cells (CRC) that express PDPN and can be lineage-traced using the Ccl19-Cre and CD21-Cre model. 18 However, a unique phenotype of CRC could not be revealed using single-cell RNA-seq analysis 7 indicating that the phenotypical distinction of FRC/FDC subsets underpinning the germinal center is still unclear.
A main fraction of FRC express markers that are indicative for their perivascular location such as Itga7 (integrin α7), Pdgfrb (CD140b), and Acta2 (αSMA) in lymph nodes 6, 7 and Ly6a (Sca-1), Pdgfra (CD140a), and Vcam1 (CD106) in the spleen. 22 It is likely that the perivascular reticular cell (PRC) fraction harbors the adult progenitor of all FRC subsets. 22, 39 Other regions of the lymph node such as the deep cortical area appear to harbor a subset of FRC that is characterized by the expression of CCL21a, CXCL12, and LepR. 19 This area of the lymph node is occupied by T cells, dendritic cells, and B cells suggesting that FRC acquire distinct phenotypical properties when they interact with multiple cell types. Indeed, FRC attain yet other properties when they co-localize in medullary cords with macrophages, NK cells, and plasma cells. 19 In this location, medullary reticular cells (medRC) express high levels of CXCL12, IL-6, and BAFF and facilitate thereby the formation of dedicated niches for plasma cells. 45 Single-cell RNA-seq analysis has confirmed the existence of at least two FRC subsets that localize in the medullary region indicating that medRC also promote the maintenance of NK cells in this region. 7 Clearly, further studies are required to unveil the molecular properties and function of FRC subsets not only in the lymph node B-cell niches but also in the different microenvironments of classical SLO.
| Limited FRC heterogeneity in nonclassical SLO and TLS
While the formation of classical SLO, ie, lymph nodes, splenic white pulp and Peyer's patches, is fully dependent on the presence of the lymphotoxinβ receptor, 46 The formation of TLS is frequently associated with chronic inflammatory and autoimmune diseases. 3, 58 Importantly, in the context of cancer, the presence of TLS correlates with improved survival in a growing list of human cancers including breast cancer, 59 lung cancer, 60 oral squamous cell 61 and Merkel cell carcinomas, 62 and melanoma. 63 Hence, it is tempting to speculate that TLS serve as inducible and transient outposts of the immune system to locally cope with ongoing immunological threats. Moreover, it appears that the coordination of immune cell interaction within these structures relies on organizational principles that are comparable to those in the classical SLO ( Figure 1C ). During tumor formation, TLS undergo a maturation process that has been suggested to start with the segregation of T-cell and B-cell areas in the perivascular space and progresses by the appearance of germinal centers. 64, 65 The subsequent development of germinal centers in tumor TLS is accompanied by the appearance of CXCL13-producing, CD21 + FDC networks both in human colorectal cancer 65 and in squamous cell carcinoma of the lung. 64 The presence of chemokine-secreting FRC that underpin TLS has been demonstrated in a variety of models of chronic organ inflammation. 52, 53, 66 The formation of inducible BALT in the lung has revealed that the activation of the innate immune system via lipopolysaccharide instillation can drive the formation of local TLS in an IL-17-dependent fashion, 50 while this cytokine is not necessary to induce BALT formation following intranasal infection with a propagation-deficient virus. 67 Nevertheless, viral infection appears to be sufficient to induce highly organized BALT structures that contain B-cell follicles underpinned by a network of CXCL13-expressing FDC as well as CXCL12-producing, yet undefined, reticular stromal cells. 66 Furthermore, the bacterial infection with Pseudomonas aeruginosa triggers BALT formation in a TLR-dependent manner leading to the emergence of CXCL12 + reticular cells that is dependent on γδ T cell-derived IL-17, while FDC fail to develop under these conditions. 66 Overall, the emerging view is that remodeling and maturation of immune-stimulating FRC is one of the initiating events in the establishment of an immune-competent niche capable of recruiting and retaining disease-relevant lymphocytes in TLS. 3 Hence, targeted modulation of FRC differentiation processes within TLS may lead to treatment modalities that either attenuate TLS formation during chronic inflammatory diseases or foster the development of such immune-activating structures in malignant diseases.
| IMMUNE CELL-FRC INTER AC TI ON S
The main function of secondary lymphoid organs is to preempt 68 and to deal with 1 the encounter of microbial agents and tumor cells. Pathogens and other antigenic material arrive at the antigensampling zone of SLO, eg, the subcapsular sinus region of lymph nodes, where dedicated macrophage/dendritic cell populations take up and transfer antigen to B cells. 69, 70 Consequently, disruption of the subcapsular sinus structure results in defective immune responses during secondary infection in mice. 71 The cellular infrastructure of the murine splenic marginal zone functions in the same manner and efficiently retains infectious agents. 72 Interestingly, it appears that the function of antigen capture and innate immunological sensing in the marginal zone of murine spleens is assigned to CD169-positive macrophages and/or dendritic cells, 69, 72 while in the human spleen MAdCAM1-positive MRC operate as coordinators of immune cell interaction and drivers of subsequent immune activation. 24 Antigens are further dispersed in the lymph node through the lymphatic sinuses that pervade the lymph node parenchyma, and are taken up by distinct dendritic cell subsets for the delivery to CD8 + or CD4 + T cells. 73 The interaction of dendritic cells and T cells depends on the infrastructure provided by TRC 74 and is regulated by TRC-derived factors such as CCL21 75 or lysophosphatidic acid. 76 The efficient interaction of T and B cells at the T-B border during viral infection depends on the presence of BAFF-producing FRC. 44 Other FRC subsets contribute during the subsequent steps of B-cell activation in lymph nodes including antigen presentation in the germinal center, 42 regulating B-cell migration during the germinal center reaction, 18, 42 and establishing plasma cell competent microenvironments in the medulla. 45 FRC can perform these multiple functions because they are able to integrate a variety of signals through sensing of innate immunological stimuli and the differentiation of cellular signals in their immediate environment ( Figure 2A ). In the following sections, we will summarize how FRC detect and process pathogen-derived innate immunological signals and illustrate the molecular pathways employed by FRC to regulate adaptive immune responses in lymph nodes, Peyer's patches and FALC. 
| Innate immunological sensing by FRC

F I G U R E 2 Fibroblastic reticular cells (FRC) coordinate innate and adaptive immune responses in lymphoid organs. (A) FRC recognize pathogen-associated molecular patterns and integrate cellular signals from immune cells such as cytokines and growth factors. A broad variety of immune cells have been shown to receive crucial signals from FRC to steers the outcome of immune responses. FRC are key decision-making cells that foster protective immunity while minimizing immunopathological damage. (B) FRC of Peyer's patches and mesenteric lymph nodes can recognize viral infection via
Toll-like receptor 7 (TLR7) and activate other immune cells through inflammatory cytokines. Concomitantly, MyD88-dependent IL-15 production is tuned down leading to attenuated type 1 innate lymphoid cell (ILC1) and natural killer (NK) cell activation. Shifting the balance between interferonγ-producing Th1 and regulatory T cell (Treg) differentiation prevents immunopathological sequelae in the intestinal lamina propria. 12 (C) Immunological sensing of bacterial products via TLR4 leads to MyD88-dependent induction of CCL2 with subsequent recruitment of inflammatory monocytes. A TNF-driven amplification of both FRC and monocyte activation drives the expansion and remodeling of FALC that grants optimal conditions for the generation of IgG antibodysecreting B cells (ASC) 8 are co-cultured with B cells in vitro. 78 Moreover, the activation of FDC by oxidized phospholipids, which function as endogenous TLR4 ligands, can foster the germinal center reaction by promoting higher rates of class-switch recombination and somatic hypermutation in B cells. 79 The formyl peptide receptor 2 that binds microbial products derived from Escherichia coli or Listeria, interacts with the endogenous ligand LL-37 to enhance CXCL13 and BAFF production by FDC and thereby promotes B-cell proliferation. 80 Viruses can directly infect FRC as demonstrated for the lymphocytic choriomeningitis virus in mice 14, 81 and human viruses including Chikungunya virus 82 or Ebola virus. 83 Complex immune cell interactions are triggered when intracellular viral RNA is recognized by FRC via TLR7 12 ( Figure 2B) . The transcriptomic analysis of lymph node FRCs after subcutaneous infection with herpes simplex virus-1 (HSV-1) revealed a pronounced activation of type-I IFN pathway in FRC. 77 Virus-induced inflammation results in FRC proliferation and the induction of a substantial remodeling of the FRC landscape. 35, 77 However, excessive activation of TLR7 ligands, eg, through internal- 87 Overall, it appears that IFNAR signaling in the stromal cell compartment is important to contain viral replication in a broad range of experimental models. However, whether and to which extent IFNAR signaling in FRC directly contributes to the control of a viral infection has not been determined yet.
Further FRC innate activation signals can be derived from immune cells that populate their particular microenvironmental niches.
For example, in murine FALC, both FRC and hematopoietic cells at-
tracted by FRC can serve as source for TNF 8 (Figure 2C ). Likewise, human tonsillar FRC respond in vitro to TNF exposure with increased expression of adhesion molecules and enhanced production of inflammatory cytokines. 88 Further consequences of innate immunological sensing by FRC include the production of T cellactivating factors such as IL-33, which is produced by splenic PDPN + FRC during vaccination with a recombinant viral vector. 89 Single-cell RNA-seq analysis has revealed a population of FRC in naive lymph nodes that express high levels of Cxcl9. 7 It appears that CXCL9 is mainly provided by stromal cells while CXCL10 is mainly express by murine myeloid cells DC following immunization of mice with dendritic cells that are pulsed with ovalbumin protein and activated with lipopolysaccharide and poly(I:C). 90 In sum, FRC actively participate in the earliest phases of developing immune responses through their function as recipients of innate immunological signals and as coordinators of subsequent immune reactions through autocrine and paracrine signal amplification.
| FRC control adaptive immune responses in lymph nodes and Peyer's patches
Molecules of the TNF receptor superfamily are not only crucial for the formation of lymphoid organs 2,46,68,91 but also profoundly impact the maturation of myofibroblastic progenitors into fully immunocompetent FRC. For example, genetic ablation of lymphotoxinβ receptor expression on Ccl19-Cre + FRC leads to defective FRC maturation with reduced expression of key molecules such as Ccl19, Ccl21, and Il7, that precipitates high susceptibility to viral infection due to impaired activation of T cells. 16 While the lymphotoxinβ receptor appears to affect the maturation of all FRC subsets in lymph nodes, other molecules from the TNF receptor superfamily appear to be required for subset specification. For example, FDC differentiation depends on TNF produced by B cells, 92 94 However, such protective FRC-immune cell interactions may precipitate immunopathological consequences such as a decreased thickness of the mucus barrier that eventually fosters intestinal inflammation. 94 Thus, FRC can function both as activating and regulating cellular entities during immune responses.
The ability of FRC to negatively impact T-cell responses has been
first noted by the Turley group who demonstrated that FRC in lymph nodes can present peripheral tissue antigens to T cells and thereby attenuate self-reactivity. 95 It has been proposed that the generation of nitric oxide by lymph nodes FRC regulates the expansion and activity of T cells. 96, 97 However, since nitric oxide can be produced by other lymph node stromal cells such as lymphatic endothelial cells, 96 it remains to be determined, for example, through FRC-specific ablation of the inducible nitric oxide synthase gene, to which extent FRC regulate T-cell activity through this mechanism. It is also possible that FRC regulate global immune responsiveness by impacting regulatory T-cell differentiation. It is generally assumed that dendritic cells are the main cell population that control the differentiation pathway of CD4 + T cells toward the FoxP3 + regulatory T-cell phenotype. 98, 99 However, a recent study suggests that FRC in mesenteric lymph nodes can modulate resident dendritic cells via a bone morphogenic protein-2-dependent pathway to foster the induction of regulatory T cells. 21 Further studies are warranted to elaborate such direct and indirect pathways of FRC-dependent immune regulation.
Innate lymphoid cells (ILC) regulate immune responsiveness by bridging innate and adaptive immunity. In contrast to T and B cells, ILC lack rearranged antigen receptors and their development and activation is therefore mainly steered via soluble factors and their receptors. Since ILC are particularly abundant at mucosal sites, they are considered as the main cell population that maintains tissue integrity and homeostasis via innate immune mechanisms. 100 ILC accumulation at mucosal surfaces relies on the provision of survival factors such as IL-7 and IL-15 that can be produced by FRC 13, 101 However, ILC also reside in SLO where they are involved in the regulation of adaptive immunity. 102, 103 Recently, it has been shown that group 1 ILC are localized in the T cell zones of Peyer's patches and that Ccl19-Cre + FRC generate an essential niche for these cells through the provision of IL-15. 12 This study shows that FRC in lymph nodes and Peyer's patches can act as immune rheostats through the regulation of group 1 ILC activity. It will be important to further elaborate the mechanisms that grant FRC in lymphoid organs control over innate and adaptive immune responses.
| FRC-dependent immune responses in FALC
In case of a breach of pathogenic microorganisms into one of the body cavities, protective immunity needs to be mounted swiftly to prevent harm to the internal organs. The adipose tissue underlying the mesothelial surface of the pericardial, pleural and peritoneal cavities harbors variable numbers of FALC. 104 In the omentum, a mesothelium-covered tissue flap that connects stomach, pancreas, colon, and spleen, FALC have been shown to collect fluids and particles from the peritoneal cavity. 105 The uptake of inflammation-inducing substances from the peritoneal cavity such as lipopolysaccharide 106 or the lipid-based antigen zymosan 47 induces an increase of omental FALC size and numbers. It has been shown that opsonization of bacterial antigens by natural, low-affinity IgM antibodies generated by peritoneal B1 B cells can promote the uptake and elimination of bacteria by myeloid cells. 107 Moreover, the presence of viral particles in the peritoneal cavity increases the cellularity and size of FALC with concomitant attraction of macrophages from the peritoneal cavity to these structures. 108 Other immune cells in the peritoneal cavity such as B-2 B cells 109 or neutrophils 110 tenance of regulatory T cells in this compartment. 113 Since IL-33 is mainly produced by FRC-like cells in FALC, 114 it is tempting to speculate that this circuit not only controls B1 B-cell activation and local IgM production during lung infection and inflammation, 114 but that FALC FRC equilibrate immune-activating and -suppressive circuits in these tissues. The regulation of physiological functions by FRC-derived IL-33 in the adipose tissue may even extend to other body functions such a thermogenesis. 115 Further studies will be required to better understand the molecular processes underlying FRC-dependent immune activation in FALC. Moreover, it will be important to dissect the relation of FALC FRC to other PDPN expression fibroblasts in visceral adipose tissues and to elaborate the mechanisms employed by FRC that contribute to the maintenance of tissue homeostasis.
| CON CLUDING REMARK S
The translation of innate immune signals into activating or regulating processes that steer adaptive immune responses has been regarded as one of the main roles of professional APC such as dendritic cells. FRC as dedicated immune-interacting fibroblasts have now entered the stage to be recognized as cells that crucially contribute to the decision-making within the immune system. The many functions of FRC are accomplished through the generation of specific microenvironmental niches for various types of immune cells.
Distinct subsets of FRC form these niches to support immune cell migration, survival, and differentiation. Interestingly, it seems that particular genetic programs are imprinted in the immune-interacting fibroblasts depending on their anatomical location. The main differentiation switches of FRC differentiation have been identified with the lymphotoxinβ receptor representing a necessary "signal 1" for FRC maturation in classical SLO. 16 However, further research needs to dissect the intercellular communication pathways between FRCs and the various immune cells that impact the differentiation trajectories of FRC in lymphoid and nonlymphoid organs. Indeed, it appears that the intestinal lamina propria of patients suffering from inflammatory bowel disease harbors at least one mesenchymal stromal cell population that closely resembles lymphoid organ FRC and is highlighted by the expression of IL-33 and Lysyl oxidases. 116 Thus, understanding the mechanisms that govern FRC differentiation in SLO and TLS will, for example, open novel avenues to target drugable FRC differentiation pathways in TLS that form during human chronic inflammatory diseases such as rheumatoid arthritis 117, 118 or Sjören's syndrome. 119 A major challenge that should to be addressed in the future is the lineage relationship of FRC with other mesenchymal cell types such as adipocytes, chondrocytes, or regular tissue fibroblasts. The definition of mesenchymal cell types needs to be coupled to their development origin and their function within a tissue. Hence, a combination of single-cell transcriptome analysis and faithful in vivo lineage tracing needs to be employed 120 to obtain consistent definitions of the cell types that are currently covered by the broad terms "stromal cells" or "mesenchymal cells".
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